Ermenegildo Zegna NV
ZGN
DexCom
DXCM
New Fortress Energy
NFE
Workday
WDAY
eBay
EBAY
US Stock MarketDetailed Quotes
LRMR Larimar Therapeutics
- 4.010
- +0.030+0.75%
Close Dec 20 16:00 ET
- 4.090
- +0.080+2.00%
Post 20:01 ET
255.86MMarket Cap-3.49P/E (TTM)
4.170High3.870Low1.14MVolume3.950Open3.980Pre Close4.59MTurnover3.61%Turnover RatioLossP/E (Static)63.81MShares13.68052wk High1.29P/B126.79MFloat Cap3.01052wk Low--Dividend TTM31.62MShs Float664.320Historical High--Div YieldTTM7.54%Amplitude1.530Historical Low4.026Avg Price1Lot Size
About Larimar Therapeutics Company
Larimar Therapeutics, Inc. Is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of novel therapeutics mitochondrial disorders and Friedreich's ataxia. The company was founded in 2005 and is headquartered in Bala Cynwyd, PA.
Company Profile
SymbolLRMR
Company NameLarimar Therapeutics
Listing DateJun 19, 2014
Issue Price16.00
Founded2005
CEODr. Carole Ben-Maimon, M.D.
MarketNASDAQ
Employees42
Fiscal Year Ends12-31
Address3 Bala Plaza East,Suite 506
CityBala Cynwyd
ProvincePennsylvania
CountryUnited States of America
Zip Code19004
Phone1-844-511-9056
Websitehttp://larimartx.com
Company Executives
- Name
- Position
- Salary
- Dr. Carole Ben-Maimon, M.D.
- Director, President and Chief Executive Officer
- 3.14M
- Dr. Russell G. Clayton, D.O.
- Chief Medical Officer
- --
- Michael Celano
- Chief Financial Officer and Principal Accounting Officer
- 1.42M
- Dr. Gopi Shankar, F.A.A.P.,M.B.A.,PhD
- Chief Development Officer
- 1.38M
- Joseph Truitt
- Chairman of the Board
- 114.96K
- Jonathan S. Leff
- Independent Director
- 79.96K
- Dr. Jeffrey W. Sherman, F.A.C.P.,M.D.
- Independent Director
- 56.43K
- Thomas Edward Hamilton
- Independent Director
- 77.77K
- Frank E. Thomas
- Independent Director
- 86.21K